Products
Reproductive Genetics
Experience
clinical-level sensitivity in embryo and fetal
genome analysis.
Preimplantation Genetic Testing (PGT) and Non-Invasive Prenatal Testing (NIPT) are highly sensitive analytical methods developed for embryo-based genetic evaluation during the in vitro fertilization (IVF) process and for screening fetal aneuploidy in the early stages of pregnancy.
For these tests in the field of reproductive genetics, we offer NGS-based solutions with high clinical accuracy, automation compatibility, and broad coverage.
With advanced bioinformatics infrastructure, validated kits, and integrated analysis workflows, we support reliable and reproducible results in laboratories.
Non-Invasive Prenatal Testing
NIPT is a highly accurate test that screens for certain genetic disorders by analyzing cell-free fetal DNA (cffDNA) circulating in the expectant mother’s blood.
It is more reliable than traditional screening methods and can be performed from the 10th week of pregnancy onwards.
Illumina VeriSeqTM NIPT v2 performs a detailed analysis of fetal DNA using the whole genome sequencing (WGS) method. This means it is not limited to specific regions and provides comprehensive genetic screening.
Trisomy
13, 18, 21
Sex chromosome
aneuploidies
Rare autosomal
aneuploidies
≥7 Mb deletions
and duplications
Chromosome
Aneuploidies
Monogenic
Diseases
Structural
Chromosomal
Abnormalities
Embryo
Selection
Genetic Counseling
Preimplantation Genetic Testing
Preimplantation Genetic Testing (PGT) is performed to assess the risk of chromosomal numerical abnormalities, translocations, and inherited monogenic diseases in embryos obtained during the IVF process.
It enables preimplantation genetic selection by providing genomic analysis at the single-cell level.